| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP00694 | 1 | SACOL2151 | 57286365 | glmM | phosphoglucosamine mutase GlmM | 451 | Drug Target Function | March 2008 | 1WQA | 35% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01456 | 1 | VC2406 | 15642403 | murE | UDP-N-acetylmuramoylalanyl-D-glutamate--... | 512 | Conserved Gene / Pathway | March 2008 | 1E8C | 50.8% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01777 | 1 | CBU_0313 | 29540926 | transglycosylase, Slt family [Coxiella b... | 487 | N/A | June 2008 | 1QSA | 9.9% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01682 | 1 | GBAA5104 | 47530405 | D-alanyl-D-alanine carboxypeptidase fami... | 286 | N/A | June 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||||
| IDP02597 | 1 | YPO3472 | 16123618 | putative sugar binding protein [Yersinia... | 437 | N/A | June 2008 | 1EU8 | 26.1% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP02399 | 1 | GBAA2559 | 47527848 | D-alanyl-D-alanine carboxypeptidase fami... | 338 | N/A | June 2008 | 1XP4 | 26.3% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP02740 | 1 | GBAA1950 | 47527245 | D-alanyl-D-alanine carboxypeptidase fami... | 285 | N/A | June 2008 | 1TVF | 28.1% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00899 | 1 | STM3294 | 16766590 | glmM | phosphoglucosamine mutase | 445 | Essential Gene | March 2008 | 1WQA | 34.6% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00802 | 1 | SACOL1704 | 57284716 | mreC | rod shape-determining protein MreC | 280 | Conserved Gene / Pathway | March 2008 | 2J5U | 29.6% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00202 | 1 | YPO2731 | 16122935 | - | putative membrane protein | 679 | Virulence | October 2007 | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||||
| IDP01103 | 1 | BA_1387 | 47605671 | D-alanine--poly(phosphoribitol) ligase s... | 79 | Drug Target Function | March 2008 | 1DV5 | 45.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP02767 | 1 | GBAA4750 | 47530050 | D-alanyl-D-alanine carboxypeptidase fami... | 259 | N/A | June 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||||
| IDP01019 | 1 | STM0228 | 16763618 | lpxA | UDP-N-acetylglucosamine acyltransferase ... | 262 | Essential Gene | March 2008 | 1LXA | 93.5% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02791 | 1 | lmo1892 | 16803931 | pbpA | hypothetical protein lmo1892 [Listeria m... | 827 | N/A | June 2008 | 2OLU | 30.8% | Listeria monocytogenes | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00668 | 1 | SACOL1196 | 57284481 | murD | UDP-N-acetylmuramoyl-L-alanyl-D-glutamat... | 449 | Conserved Gene / Pathway | March 2008 | 2JFF | 31.4% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00417 | 1 | YPO2604 | 16122817 | pbpA | penicillin-binding protein 2 | 631 | Drug Target Function | March 2008 | 1MWR | 23.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02154 | 1 | GBAA2526 | 47527815 | D-alanyl-D-alanine carboxypeptidase fami... | 243 | N/A | June 2008 | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||||
| IDP01457 | 1 | VC2407 | 15642404 | penicillin-binding protein 3 | 580 | Drug Target Function | March 2008 | 3EQU | 34% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00860 | 1 | STM1910 | 16765252 | putative penicillin-binding protein | 623 | Drug Target Function | March 2008 | 1MWR | 24.9% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00022 | 1 | BA_5578 | 81714842 | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 429 | Drug Target Homolog | October 2007 | 1EJC | 44.8% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01078 | 1 | STM4137 | 16767396 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 342 | Essential Gene | March 2008 | 1MBB | 82.2% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01248 | 1 | BA_3554 | 30258085 | penicillin-binding protein, putative | 377 | Drug Target Function | March 2008 | 2QMI | 22.3% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00982 | 1 | STM2062 | 16765392 | dacD | D-alanyl-D-alanine carboxypeptidase | 390 | Drug Target Function | March 2008 | 1NZO | 45.1% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02731 | 1 | CBU_0124 | 29540744 | murF | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,... | 446 | N/A | June 2008 | 1GG4 | 43.9% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01836 | 1 | Cj1659 | 6969064 | iamA | putative ABC transport system ATP-bindin... | 179 | N/A | June 2008 | 2O6C | 31.8% | Campylobacter jejuni | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00229 | 1 | YPO0417 | 16120750 | - | putative O-antigen biosynthesis protein | 410 | Virulence | October 2007 | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||||
| IDP01455 | 1 | VC2405 | 15642402 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,... | 453 | Conserved Gene / Pathway | March 2008 | 1GG4 | 52.5% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01499 | 1 | VCA0870 | 15601625 | pbpG | D-alanyl-D-alanine endopeptidase | 316 | Drug Target Function | March 2008 | 1ES4 | 24.1% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01453 | 1 | VC2401 | 15642398 | murG | N-acetylglucosaminyl transferase | 354 | Conserved Gene / Pathway | March 2008 | 1F0K | 63.8% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02024 | 1 | CBU_0131 | 29540751 | murD | UDP-N-acetylmuramoylalanine--D-glutamate... | 442 | N/A | June 2008 | 1E0D | 43% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00822 | 1 | SACOL2253 | 57285032 | femX | femX protein | 421 | Conserved Gene / Pathway | March 2008 | 1LRZ | 27.3% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01224 | 1 | BA_4054 | 30258561 | sporulation specific penicillin-binding ... | 638 | Drug Target Function | March 2008 | 1PYY | 26.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00007 | 1 | BA_0847 | 30254435 | racE-1 | glutamate racemase | 276 | Drug Target Homolog | October 2007 | 2DWU | 100% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01407 | 1 | VC0947 | 15640963 | D-alanyl-D-alanine carboxypeptidase | 391 | Drug Target Function | March 2008 | 1NZO | 52.2% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01245 | 1 | BA_2637 | 30257254 | penicillin-binding protein | 708 | Drug Target Function | March 2008 | 1MWR | 21% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00789 | 1 | SACOL1066 | 57284436 | fmt protein | 397 | Conserved Gene / Pathway | March 2008 | 2QMI | 16.1% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01207 | 1 | BA_2610 | 39930865 | D-alanine--D-alanine ligase (D-alanylala... | 304 | Conserved Gene / Pathway | March 2008 | 1E4E | 37.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP02327 | 1 | YPO1320 | 16121602 | dacC | D-alanyl-D-alanine carboxypeptidase [Yer... | 432 | N/A | June 2008 | 1NZO | 55.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02037 | 1 | CBU_0135 | 29540755 | murG | UDP-N-acetylglucosamine--N-acetylmuramyl... | 358 | N/A | June 2008 | 1F0K | 46.6% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01251 | 1 | BA_4606 | 30259106 | penicillin-binding protein | 584 | Drug Target Function | March 2008 | 3EQV | 23.1% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00462 | 1 | YPO1025 | 16121325 | mltA | murein transglycosylase A | 390 | Drug Target Function | March 2008 | 2GAE | 62.8% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00306 | 1 | CBU_0137 | 29653495 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 316 | Drug Target Function | March 2008 | 1HSK | 34.5% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01243 | 1 | BA_2345 | 30256982 | penicillin-binding protein 1A | 820 | Drug Target Function | March 2008 | 2OLU | 29.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00226 | 1 | YPO3938 | 16124066 | glgP | glycogen phosphorylase | 815 | Virulence | October 2007 | 1EM6 | 49.9% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02617 | 1 | GBAA1286 | 47526551 | D-alanyl-D-alanine carboxypeptidase fami... | 428 | N/A | June 2008 | 1XP4 | 21.7% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01252 | 1 | BA_5623 | 30260075 | penicillin-binding protein | 683 | Drug Target Function | March 2008 | 2OLU | 27.5% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00595 | 1 | YPO3760 | 16123897 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 345 | Drug Target Function | March 2008 | 1MBB | 60.9% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01488 | 1 | VCA0572 | 15601331 | ddl | D-alanyl-alanine synthetase A | 334 | Conserved Gene / Pathway | March 2008 | 2FB9 | 34.1% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00674 | 1 | SACOL1453 | 57286104 | murG | N-acetylglucosaminyl transferase | 356 | Drug Target Function | March 2008 | 1F0K | 25.6% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00688 | 1 | SACOL2060 | 57284928 | alr | alanine racemase | 382 | Conserved Gene / Pathway | March 2008 | 1BD0 | 42.7% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01242 | 1 | BA_1572 | 30255873 | penicillin-binding protein | 897 | Drug Target Function | March 2008 | 2OLU | 27.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01246 | 1 | BA_2648 | 30257265 | penicillin-binding protein | 712 | Drug Target Function | March 2008 | 1QME | 29.9% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00592 | 1 | YPO3393 | 16123542 | mrcB | penicillin-binding protein 1b | 824 | Virulence Associated Factor | March 2008 | 2JCH | 19.3% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02576 | 1 | GBAA0246 | 47525503 | murF | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,... | 458 | N/A | June 2008 | 2AM1 | 37.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00903 | 1 | STM0123 | 16763513 | murE | UDP-N-acetylmuramoylalanyl-D-glutamate--... | 495 | Essential Gene | March 2008 | 1E8C | 91.5% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00905 | 1 | STM0126 | 16763516 | murD | UDP-N-acetylmuramoyl-L-alanyl-D-glutamat... | 438 | Essential Gene | March 2008 | 1E0D | 92.2% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01676 | 1 | CBU_0869 | 29541462 | alr | alanine racemase [Coxiella burnetii RSA ... | 364 | N/A | June 2008 | 2RJG | 42.6% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02225 | 1 | CBU_1338 | 29541903 | D-alanine--D-alanine ligase [Coxiella bu... | 372 | N/A | June 2008 | 2I80 | 36.6% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01241 | 1 | BA_1474 | 30255405 | penicillin-binding protein | 673 | Drug Target Function | March 2008 | 2JCH | 28.8% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00794 | 1 | SACOL1194 | 57284479 | pbp1 | penicillin-binding protein 1 | 744 | Drug Target Function | March 2008 | 1PYY | 30.9% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02223 | 1 | YPO0550 | 16120878 | murE | UDP-N-acetylmuramoylalanyl-D-glutamate--... | 490 | N/A | June 2008 | 1E8C | 76.9% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00309 | 1 | CBU_0298 | 29653649 | murI | glutamate racemase | 280 | Drug Target Function | March 2008 | 2GZM | 38.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP02666 | 1 | GBAA1490 | 47777937 | D-alanyl-D-alanine carboxypeptidase fami... | 374 | N/A | June 2008 | 1TVF | 24.1% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01250 | 1 | BA_4497 | 30259003 | penicillin-binding protein | 706 | Drug Target Function | March 2008 | 2Z2L | 14.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00018 | 1 | BA_4717 | 30259210 | racE-2 | glutamate racemase | 269 | Drug Target Homolog | October 2007 | 2GZM | 99.3% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01253 | 1 | BA_2575 | 30257197 | penicillin-binding protein, putative | 481 | Drug Target Function | March 2008 | 2QMI | 20% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00425 | 1 | YPO3863 | 16123998 | wecC | UDP-N-acetyl-D-mannosamine dehydrogenase... | 420 | Conserved Gene / Pathway | March 2008 | 2O3J | 29.8% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00658 | 1 | SACOL0801 | 57285762 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 307 | Drug Target Function | March 2008 | 1HSK | 99.3% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01209 | 1 | BA_2650 | 30257267 | penicillin-binding protein | 340 | Drug Target Function | March 2008 | 2QMI | 27.1% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00591 | 1 | YPO0145 | 161486893 | mrcA | penicillin-binding protein | 859 | Drug Target Function | March 2008 | 2JCH | 21% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01244 | 1 | BA_2504 | 30257132 | penicillin-binding protein | 588 | Drug Target Function | March 2008 | 1MWR | 23.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01231 | 1 | BA_4684 | 30259179 | mreB | rod shape-determining protein MreB | 339 | Drug Target Function | March 2008 | 1JCE | 52.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00021 | 1 | BA_5529 | 81714862 | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 434 | Drug Target Homolog | October 2007 | 1NAW | 50.7% | Bacillus anthracis | Cell env | |||||||||||||||||||